First Time Loading...

Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 19.62 HKD 1.03% Market Closed
Updated: May 6, 2024

Sinopharm Group Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sinopharm Group Co Ltd
Operating Income Peer Comparison

Comparables:
S
601607
600998
C
600511
000963
C
000028

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
¥22.9B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
16%
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
¥8.9B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
12%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
¥3.9B
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
18%
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
¥2.4B
CAGR 3-Years
16%
CAGR 5-Years
5%
CAGR 10-Years
21%
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
¥3.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
15%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Operating Income
¥2.4B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
12%

See Also

What is Sinopharm Group Co Ltd's Operating Income?
Operating Income
22.9B CNY

Based on the financial report for Jun 30, 2023, Sinopharm Group Co Ltd's Operating Income amounts to 22.9B CNY.

What is Sinopharm Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%

Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Sinopharm Group Co Ltd have been 10% over the past three years , 10% over the past five years , and 16% over the past ten years .